The migraine WHAT! study focusses on the role of hormones in women with migraine. WHAT stands for “Women, Hormones, Attacks and Treatment”.
Newspaper: women respond different to medication
Men and women respond different to medication. Researchers from the Leiden University Medical Center and Erasmus MC discovered that triptans are a good example. Women experience more side effects, for example. Nevertheless, they are prescribed the same dosage as men. Read the full article here (in Dutch).
RADAR+ Interview with prof. dr. Terwindt
Two million Dutch people suffer from migraine, women twice as often as men. Acute medication is less effective in women. Prof. dr. Terwindt from the LUMC: ‘Women with migraine have the right to better answers’. Read the full article here (in Dutch).
Less benefits, more side effects
Women benefit less from triptans – migraine drugs – than men. In addition, women more often suffer from side effects. This was demonstrated in a study by the LUMC and Erasmus MC. Read more in this interview in Leidsch Dagblad (in Dutch).